Articles/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis 3 Questions on biosimilars in Europe: Adrian van den Hoven Andrew McConaghie biosimilars, biosimilars Europe, cancer biosimilars, Medicines for Europe 0 Comment Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018. Share X 3 Questions on biosimilars in Europe: Adrian van den Hoven https://pharmaphorum.com/views-and-analysis/biosimilars-3-questions-adrian-van-den-hoven-medicines-europe/